What determines referral of UK patients with haematological malignancies to palliative care services? An exploratory study using hospital records

Abstract

We investigated the frequency and characteristics of patients with haematological malignancies (HMs) who were, or were not, referred for specialist palliative care (SPC). Data were abstracted from hospital records of 108 patients who died — 27 with leukaemia, 11 with myelodysplastic syndromes, 48 with lymphoma and 22 with myeloma. Ninety-three patients (86.1%) were >60 years of age at diagnosis, with 33 (30.6%) being ≥80 years and 31 (28.7%) having existing comorbidities. Thirty-three patients (30.6%) were referred to SPC services. There was little difference by age or HM diagnosis in referred patients. Seventeen of 67 patients (25.4%) dying on a hospital ward received SPC compared with 6/7 (85.7%) dying at home. Time between diagnosis and death influenced the referral — 24/52 patients (46.2%) dying ≥30 days after diagnosis received SPC compared with 8/42 (19.1%) dying within 30 days. In 14 patients, HM diagnosis was confirmed after death. Identification of these 14 patients is likely to be a unique feature of our study, as patients were selected from a regional, population-based register with centralized diagnostic services, enabling the identification of all patients with HM. The interface between curative and palliative treatment in HM is more complex than the National Institute for Clinical Excellence recommendations suggest. Palliative Medicine 2007; 21 : 487—492

Keywords

comorbidity haematological malignancy palliative care services

Get full access to this article

View all access options for this article.

References

National Institute for Clinical Excellence. Improving outcomes in haematological cancers. The manual. National Institute for Clinical Excellence, October 2003.

National Institute for Clinical Excellence. Improving outcomes in haematological cancers. The research evidence. National Institute for Clinical Excellence, November 2003.

Auret K. , Bulsara C. , Joske D. Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J 2003; 33: 566—71.

Hunt RW , Fazekas BS , Luke CG , Priest KR , Roder DM The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999. Palliat Med 2002; 16: 403—9.

McGrath P. End-of-life care for hematological malignancies: the `technological imperative' and palliative care. J Palliat Care 2002; 18(1): 39—47.

McGrath P. , Holewa H. Missed opportunities: nursing insights on end-of-life care for haematology patients. Int J Nurs Pract 2006; 12(5): 295—301.

McGrath P. , Holewa H. Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care 2007; 16(2): 164—71.

Addington-Hall J. , Altmann D.

Which terminally ill cancer patients in the United Kingdom receive care from community specialist palliative care nurses?

J Adv Nurs 2000; 32(4): 799—806.

Wedding U. , Roehrig B. , Klippstein A. , Steiner P. , Schaeffer T. , Pientka L. , Hoeffken K. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol 2007; 61(3): 269—76.

10.

Ellershaw JE , Wilkinson S. Care of the dying: a pathway to excellence. Oxford University Press, 2003.

11.

Liverpool Care Pathway for the Dying Patient, Retrieved 18 July 2007, from www.mcpcil.org.uk/liverpool_care_pathway .

12.

Watson J. , Hockley J. , Dewar B. Barriers to implementing an integrated pathway for the last days of life in nursing homes. Int J Palliat Nurs 2006; 12(5): 234—40.

13.

Hallberg IR Palliative care as a framework for older people's long-term care. Int J Palliat Nurs 2006; 12(5): 224—9.